Alzheimer's DiseaseLecanemabDrug Approval
Canada Approves First Alzheimer's Disease-Modifying Drug
On October 25, 2025, Health Canada approved lecanemab, marketed as Leqembi, making it the first disease-modifying treatment for Alzheimer's disease available to Canadian patients. Unlike existing Al
PlusVirtual TeamOct 27, 2025